Biblio
Found 1 results
Filters: Keyword is Neoplasm Recurrence, Local and Author is Bearelly, Shethal [Clear All Filters]
.
2023. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.